Johnson & Johnson’s (J&J) Shockwave Medical unit has reported that its Javelin peripheral intravascular lithotripsy (IVL) ...

PORTLAND, OR, UNITED STATES, January 6, 2025 /EINPresswire / -- The global shockwave therapy market is experiencing significant growth, with its size valued at approximately $1,171.19 million in ...

Amplitude Vascular Systems (AVS), developer of the Pulse intravascular lithotripsy (PIVL) platform for the treatment of ...

The Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter received PMA approval in February 2021 and is indicated for lithotripsy-enabled, low-pressure balloon dilatation of severely ...

based Shockwave, which was founded in 2009 ... with significant unmet patient need,” said the statement. IVL is a “minimally invasive, catheter-based treatment for calcified arterial lesions ...

We believe the differentiated efficiency of this device versus other IVL catheters will be an important solution for our carotid disease patients, where a shorter treatment time is of utmost ...

Dawkins, MD, Chief Medical Officer of Shockwave Medical. “This new evidence showing the consistency of IVL confirms that this platform technology has a critical role to play in not just ...

Amplitude Vascular Systems (AVS), a medical device company focused on safely and effectively treating severely calcified arterial disease with its nov ...